Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30088483HIVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS30063793HIVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS30063794HIVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS20008491HPVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS20043606HPVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS20023643HPVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TCGA Plot Options
Drug Information
GeneHTR4
DrugBank IDDB04873
Drug NamePiboserod
Target IDBE0000084
UniProt IDQ13639
Regulation Type
PubMed IDs15902472; 16495076
CitationsDarblade B, Behr-Roussel D, Gorny D, Lebret T, Benoit G, Hieble JP, Brooks D, Alexandre L, Giuliano F: Piboserod (SB 207266), a selective 5-HT4 receptor antagonist, reduces serotonin potentiation of neurally-mediated contractile responses of human detrusor muscle. World J Urol. 2005 Jun;23(2):147-51. Epub 2005 May 18.@@McCullough JL, Armstrong SR, Hegde SS, Beattie DT: The 5-HT2B antagonist and 5-HT4 agonist activities of tegaserod in the anaesthetized rat. Pharmacol Res. 2006 Apr;53(4):353-8. Epub 2006 Feb 21.
GroupsInvestigational
Direct ClassificationIndolecarboxamides and derivatives
SMILESCCCCN1CCC(CNC(=O)C2=C3OCCCN3C3=CC=CC=C23)CC1
Pathways
PharmGKB
ChEMBLCHEMBL356359